GHK-Cu is typically associated with collagen signaling, skin remodeling, and tissue regeneration, while BPC-157 is more often discussed in relation to tendon, ligament, muscle, gut, and musculoskeletal recovery models
Research overwhelmingly describes the safety of GHK-Cu positively, such as when the authors of a 2018 review called it a safe, inexpensive, extensively studied compound.14 However, even though copper peptides have demonstrated an impressive safety track record in studies, there are (as with most skin care actives) a few safety risks to consider
doi: 10.1210/jc.2016-2587 15 DoraJMMaChadoWERheinheimerJCrispimDMaiaAL
1991 (landmark Italian trial): A double-blind, placebo-controlled trial involving 130 patients with Alzheimer's disease demonstrated that one year of ALCAR treatment resulted in a slower rate of deterioration compared to placebo across 13 of 14 outcome measures, including significant improvements in the Blessed Dementia Scale, logical intelligence, verbal critical abilities, long-term verbal memory, and selective attention [5][17]
Immediately after the gastric ulcer induction, COX-2-selective inhibitor NS-398 (2 mg/kg/day
Upon reconstitution in sterile water or 0.9% saline at concentrations of 15 mg/mL, stability at 4C is approximately 30 days